Ingebjørg Seljeflot

11.6k total citations
321 papers, 8.2k citations indexed

About

Ingebjørg Seljeflot is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Ingebjørg Seljeflot has authored 321 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Cardiology and Cardiovascular Medicine, 57 papers in Molecular Biology and 54 papers in Surgery. Recurrent topics in Ingebjørg Seljeflot's work include Acute Myocardial Infarction Research (55 papers), Adipokines, Inflammation, and Metabolic Diseases (38 papers) and Atrial Fibrillation Management and Outcomes (37 papers). Ingebjørg Seljeflot is often cited by papers focused on Acute Myocardial Infarction Research (55 papers), Adipokines, Inflammation, and Metabolic Diseases (38 papers) and Atrial Fibrillation Management and Outcomes (37 papers). Ingebjørg Seljeflot collaborates with scholars based in Norway, Denmark and United States. Ingebjørg Seljeflot's co-authors include Harald Arnesen, Svein Solheim, Jan Eritsland, Michael Abdelnoor, Marius Trøseid, Trine B. Opstad, Alf‐Åge R. Pettersen, Mette Hurlen, Geir Øystein Andersen and Elsa M. Hjerkinn and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Ingebjørg Seljeflot

315 papers receiving 7.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingebjørg Seljeflot Norway 48 2.9k 1.6k 1.4k 1.3k 1.3k 321 8.2k
Yoshihiro Kokubo Japan 50 2.3k 0.8× 1.2k 0.7× 1.2k 0.9× 1.0k 0.8× 956 0.7× 247 8.2k
Roberto Carnevale Italy 49 1.7k 0.6× 1.2k 0.8× 1.6k 1.2× 1.8k 1.3× 806 0.6× 236 7.8k
Franco Cuccurullo Italy 52 2.6k 0.9× 1.8k 1.1× 1.5k 1.1× 985 0.7× 726 0.6× 193 9.1k
Hideki Origasa Japan 47 3.4k 1.2× 2.3k 1.4× 828 0.6× 762 0.6× 2.0k 1.6× 254 9.6k
Giovanni Ciabattoni Italy 64 3.6k 1.2× 1.6k 1.0× 1.6k 1.1× 2.2k 1.7× 828 0.6× 169 12.0k
Jacek Rysz Poland 52 2.7k 0.9× 2.8k 1.7× 1.9k 1.4× 1.2k 0.9× 699 0.5× 360 10.3k
Elmo Mannarino Italy 50 2.9k 1.0× 1.6k 1.0× 1.0k 0.7× 957 0.7× 501 0.4× 206 7.6k
Gerasimos Siasos Greece 48 3.0k 1.0× 1.6k 1.0× 1.9k 1.4× 937 0.7× 451 0.4× 414 8.1k
Giovanni Davı̀ Italy 61 5.0k 1.7× 3.0k 1.9× 1.8k 1.3× 1.5k 1.1× 904 0.7× 219 13.5k
Harald Arnesen Norway 60 6.8k 2.3× 3.4k 2.2× 1.6k 1.1× 1.1k 0.8× 1.5k 1.2× 351 13.5k

Countries citing papers authored by Ingebjørg Seljeflot

Since Specialization
Citations

This map shows the geographic impact of Ingebjørg Seljeflot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingebjørg Seljeflot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingebjørg Seljeflot more than expected).

Fields of papers citing papers by Ingebjørg Seljeflot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingebjørg Seljeflot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingebjørg Seljeflot. The network helps show where Ingebjørg Seljeflot may publish in the future.

Co-authorship network of co-authors of Ingebjørg Seljeflot

This figure shows the co-authorship network connecting the top 25 collaborators of Ingebjørg Seljeflot. A scholar is included among the top collaborators of Ingebjørg Seljeflot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingebjørg Seljeflot. Ingebjørg Seljeflot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aune, S., Ragnhild Helseth, Are A. Kalstad, et al.. (2024). Links Between Adipose Tissue Gene Expression of Gut Leakage Markers, Circulating Levels, Anthropometrics, and Diet in Patients with Coronary Artery Disease. Diabetes Metabolic Syndrome and Obesity. Volume 17. 2177–2190. 3 indexed citations
2.
Raju, Sajan C., Antonio Molinaro, Ayodeji Awoyemi, et al.. (2024). Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity. Genome Medicine. 16(1). 27–27. 16 indexed citations
3.
Myhre, Peder L., Trygve Berge, Are A. Kalstad, et al.. (2023). Omega-3 fatty acid supplements and risk of atrial fibrillation and ‘micro-atrial fibrillation’: A secondary analysis from the OMEMI trial. Clinical Nutrition. 42(9). 1657–1660. 6 indexed citations
4.
Kalstad, Are A., Peder L. Myhre, Svein Solheim, et al.. (2023). von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction. Research and Practice in Thrombosis and Haemostasis. 7(4). 100164–100164.
5.
Raju, Sajan C., Kaspar Broch, Cristiane C.K. Mayerhofer, et al.. (2023). Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure. Frontiers in Cardiovascular Medicine. 10. 1160030–1160030. 5 indexed citations
6.
Chaban, Viktoriia, Espen Rostrup Nakstad, Henrik Stær-Jensen, et al.. (2021). Complement activation is associated with poor outcome after out-of-hospital cardiac arrest. Resuscitation. 166. 129–136. 16 indexed citations
7.
Opstad, Trine B., Alf‐Åge R. Pettersen, Harald Arnesen, et al.. (2020). Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease. Mediators of Inflammation. 2020. 1–9. 11 indexed citations
9.
Seljeflot, Ingebjørg, et al.. (2018). Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease. Cytokine. 105. 17–22. 11 indexed citations
10.
11.
Enger, Steve, et al.. (2016). Troponin I levels in permanent atrial fibrillation—impact of rate control and exercise testing. BMC Cardiovascular Disorders. 16(1). 79–79. 3 indexed citations
12.
Pettersen, Alf‐Åge R., Harald Arnesen, & Ingebjørg Seljeflot. (2015). A brief review on high on-aspirin residual platelet reactivity. Vascular Pharmacology. 67-69. 6–9. 24 indexed citations
13.
Edvardsen, Elisabeth, et al.. (2014). Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease. Diabetology & Metabolic Syndrome. 6(1). 36–36. 14 indexed citations
14.
Lindholm, Espen, et al.. (2013). The Anesthesia in Abdominal Aortic Surgery (ABSENT) Study. Anesthesiology. 119(4). 802–812. 32 indexed citations
15.
Husebye, Trygve, Jan Eritsland, Carl Müller, et al.. (2013). Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study. European Journal of Heart Failure. 15(5). 565–572. 80 indexed citations
17.
Weiss, Thomas W., Harald Arnesen, Marius Trøseid, et al.. (2011). Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose. Wiener klinische Wochenschrift. 123(21-22). 650–654. 14 indexed citations
18.
Lindman, Anja Schou, Jan I. Pedersen, Elsa M. Hjerkinn, et al.. (2005). The influence of the −401G/T and −402G/A polymorphisms of the coagulation FVII promoter on plasma levels of FVII. Thrombosis Research. 116(4). 313–320. 4 indexed citations
19.
Lindman, Anja Schou, Jan I. Pedersen, Harald Arnesen, et al.. (2004). Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease. Thrombosis Research. 113(1). 57–65. 12 indexed citations
20.
Keber, Irena, et al.. (2001). Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. Journal of Internal Medicine. 250(6). 508–515. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026